Drug Recall, Generic Bone Cancer Medication Launch Highlights Specialty Pharmacy Week in Review

A look back at the top stories on Specialty Pharmacy Times from May 4 to May 8.

A look back at the top stories on Specialty Pharmacy Times from May 4 to May 8.

Delaying Hepatitis C Treatment Increases Death Risk

Delays can negatively affect treatment efficacy and the risk of morbidity and mortality among patients.

http://www.specialtypharmacytimes.com/news/Delaying-Hepatitis-C-Treatment-Increases-Death-Risk

Vaccine Enhances Effect of HIV Drugs

Boosting immune system improves efficacy of antiretroviral drugs.

http://www.specialtypharmacytimes.com/news/Vaccine-Enhances-Effect-of-HIV-Drugs

Hepatitis C Increases Likelihood of Cancer Diagnosis

Cancer rates significantly greater compared with non-infected individuals.

http://www.specialtypharmacytimes.com/news/Hepatitis-C-Increases-Likelihood-of-Cancer-Diagnosis

Generic Levoleucovorin Launched by Sandoz

Levoleucovorin is for rescue use after high-dose methotrexate therapy in bone cancer.

http://www.specialtypharmacytimes.com/news/Generic-Levoleucovorin-Launched-by-Sandoz

Prime Time for HIV Prevention Counseling

Expanded hours may be needed to overcome treatment obstacles.

http://www.specialtypharmacytimes.com/news/Prime-Time-for-HIV-Prevention-Counseling

Lung Cancer Mortality May be Lowered by Long-Term Statin Use

Researchers find significant reduction in lung cancer-specific deaths.

http://www.specialtypharmacytimes.com/news/Lung-Cancer-Mortality-May-be-Lowered-by-Long-Term-Statin-Use

HIV Increases Risk of Age-Related Vision Loss

Age-related macular degeneration greater in HIV-infected patients.

http://www.specialtypharmacytimes.com/news/HIV-Increases-Risk-of-Age-Related-Vision-Loss

Teva Recalls Adrucil Injections Distributed to Pharmacies

Particulate matter found in 8 lots of Adrucil 50 mg/mL.

http://www.specialtypharmacytimes.com/news/Teva-Recalls-Adrucil-Injections-Distributed-to-Pharmacies

Diet Effects Colon Cancer Risk

Diets with more animal protein and less soluble fiber increases cancer risk.

http://www.specialtypharmacytimes.com/news/Diet-Effects-Colon-Cancer-Risk

Extended Hemophilia Treatment Safe and Effective in Children

Combination of recombinant factor VIII with a fusion protein allows for less frequent treatment.

http://www.specialtypharmacytimes.com/news/Extended-Hemophilia-Treatment-Safe-and-Effective-in-Children

Telomerase-Inhibition May Change Cancer Treatment

Genetically determined telomere length may not influence mortality.

http://www.specialtypharmacytimes.com/news/Telomerase-Inhibition-May-Change-Cancer-Treatment

Subdermal Implant Delivers Potent HIV Therapy

Implant delivers sustained release of ARV drugs up to 40 days with no adverse side effects.

http://www.specialtypharmacytimes.com/news/Subdermal-Implant-Delivers-Potent-HIV-Therapy